Blood Vessels News and Research

RSS

Risks outweigh benefits of shark cartilage as anti-cancer treatment

As a treatment for advanced cancer, shark cartilage fails to benefit patients and its adverse effects lead to poor compliance.

23 May 2005

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.

20 May 2005

Bacteria in plaque may increase risk for heart attacks

Researchers have found evidence that the amount of bacteria in subgingival plaques, the deep plaques in periodontal pockets and around the teeth, may contribute to an individual's risk of a heart attack, according to two studies appearing the Journal of Periodontology.

20 May 2005

Two out of three Americans with type-2 diabetes do not have their disease under control

According to a new survey two out of three Americans with type-2 diabetes do not have their disease under control and are putting themselves at risk of early deaths from stroke, heart attack or kidney failure as well as blindness and limb loss.

18 May 2005

Advanced breast cancer drug appears effective on multiple targets

An experimental breast cancer drug that simultaneously attacks five tumor targets has halted progression of the disease in a clinical trial for patients with advanced disease.

18 May 2005

Tumor vasculature has become an attractive target in the treatment of cancer.

Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

17 May 2005

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Researchers showed that the immune system can brand foreign proteins by chemically modifying their structure, and that these modifications increased the chances that cells known as lymphocytes would recognize the trespassers and attack them.

17 May 2005

Engineers have found a way to modify a plastic to anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes

In the study led by Dr. Christine Schmidt, the researchers identified a piece of protein from among a billion candidates that could perform the unusual feat of attaching to polypyrrole, a synthetic polymer (plastic) that conducts electricity and has shown promise in biomedical applications.

17 May 2005

SU11248 drug show promise against neuroendocrine tumors-stubborn cancers that respond poorly to chemotherapy

A unique, targeted anti-cancer drug appears to show promise against neuroendocrine tumors-stubborn cancers that have traditionally responded poorly to chemotherapy, according to research findings announced at the 2005 Annual Meeting of the American Society of Clinical Oncology (ASCO).

17 May 2005

Stents coated in polytetrafluoroethylene help keep blood vessels open for cirrhosis patients

Stents coated in polytetrafluoroethylene, the same substance used in non-stick cooking utensils, improves their ability to keep blood vessels open in TIPS procedures, decreasing occurrences of relapse and avoiding intervention, say a group of researchers led by Vina C. Williams, MD, from Leiden University Medical Center in the Netherlands.

17 May 2005

Antibody combined with cancer drug shows promise against breast tumors

An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug, according to researchers at UT Southwestern Medical Center.

16 May 2005

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

16 May 2005

Emerging evidence supports early detection, monitoring, and in some cases treatment for children suffering from high blood pressure

One year after recommending that children should be checked for high blood pressure starting at age 3, medical experts reviewed additional supporting evidence for the pediatric blood pressure guidelines at the American Society of Hypertension's Twentieth Annual Meeting (ASH 2005).

16 May 2005

Exaggerated blood pressure reaction to mental stress predicts cardiovascular risk

When mental stress sparks a significant rise in blood pressure, it may be a sign of other existing cardiovascular risk factors, researchers reported today at the American Society of Hypertension’s Twentieth Annual Scientific Meeting.

16 May 2005

Erectile dysfunction, high blood pressure linked

Men with high blood pressure have a new reason to get their condition under control – they may be at risk for erectile dysfunction, medical experts announced at the American Society of Hypertension’s Twentieth Annual Scientific Meeting.

16 May 2005

Distributing medications in specially designed blister packages rather than in bottles may increase the likelihood that medications will be taken properly

The study found that patients taking lisinopril – a medication used to treat chronic high blood pressure – were more likely to have their prescriptions refilled on time if the medication came in a blister package rather than as loose tablets in a bottle. In this case, the blister package clearly started the day on which to take each pill.

16 May 2005

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.

16 May 2005

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Patients with a particular type of advanced lung cancer may have a new option based on data presented at the 2005 annual meeting of the American Society of Clinical Oncology showing that combining a drug that cuts off the cancer's blood supply with standard chemotherapy can shrink tumors and extend life.

15 May 2005

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

15 May 2005

Broader range of treatments for excessive sweating disorder, Mayo Clinic Proceedings says

The often embarrassing, excessive sweating disorder, hyperhidrosis, and its treatment options are gaining greater attention from physicians. This is improving the efficacy of treatment and minimizing its adverse effects, Mayo Clinic authors write in the May issue of Mayo Clinic Proceedings.

11 May 2005

Blood Vessels News and Research

Risks outweigh benefits of shark cartilage as anti-cancer treatment

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Bacteria in plaque may increase risk for heart attacks

Two out of three Americans with type-2 diabetes do not have their disease under control

Advanced breast cancer drug appears effective on multiple targets

Tumor vasculature has become an attractive target in the treatment of cancer.

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Engineers have found a way to modify a plastic to anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes

SU11248 drug show promise against neuroendocrine tumors-stubborn cancers that respond poorly to chemotherapy

Stents coated in polytetrafluoroethylene help keep blood vessels open for cirrhosis patients

Antibody combined with cancer drug shows promise against breast tumors

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

Emerging evidence supports early detection, monitoring, and in some cases treatment for children suffering from high blood pressure

Exaggerated blood pressure reaction to mental stress predicts cardiovascular risk

Erectile dysfunction, high blood pressure linked

Distributing medications in specially designed blister packages rather than in bottles may increase the likelihood that medications will be taken properly

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Broader range of treatments for excessive sweating disorder, Mayo Clinic Proceedings says

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News